|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Pharmacokinetics, safety, and tolerability of ascending single doses of moxifloxacin, a new 8-methoxy quinolone, administered to healthy subjects 显示文摘 | Stass H Dalhoff A Kubitza D | 1998 | Antimicrob Agents Chemother1998，42，8： | 1 |
| 2 | Pharmacokinetics, safety,and tolerbility of ascending single doses of Moxifloxacin, a new 8-methoxy quinolone, administered to healthy subjects显示文摘 | Stass H Dalhoff A Kubitza D | 1998 | Antimicrob Agents Chemothe1998，42，8： | 1 |
| 3 | Pharmacokinetics, safety, and tolerability of ascending singledoses of moxifloxacin, a new 8-rnethoxyquinolone, administered to healthy subjects显示文摘 | Stass H Dalhoff A Kubitza D | 1998 | 42(8): 2060-20651998，42，8： | 1 |
| 4 | Redefining penems显示文摘 | Dalhoff A Janjic N Echols R | 2006 | Biochem Pharmacol2006，71，7： | 1 |
| 5 | Beta-lactamase stability of faropenem显示文摘 | Dalhoff A Nasu T Okamoto K | 2003 | Chemotherapy2003，49，： | 1 |
| 6 | Beta - lactamase stability of faro- penem 显示文摘 | Dalhoff A Nasu T Okamoto K | 2003 | Chemotherapy2003，49，： | 1 |
| 7 | Pharmacokinetics,Safety,and Tolerability of Ascending Single Doses of Moxifloxacin,a New 8-Methoxy Quinolone,Administered to Healthy Subjects显示文摘 | Stass H Dalhoff A Kubitua D | 1998 | Antimicrob Agents Chemother1998，42，8： | 1 |
| 8 | The in vitro activity of moxifloxacin against legionella species and the effects of medium on susceptibility test results显示文摘 | Dalhoff A | 1999 | J Antimicrob Chemother1999，43，： | 1 |
| 9 | Pharmacokinetics,safety,and tolerability of ascending single doses of moxifloxacin,a new 8-methoxy guinolone,administered to healthy subjects显示文摘 | Dalhoff A Kubitza D | 1998 | Antimicrob Agents Chemother1998，42，： | 1 |
| 10 | Okamotob target affinities of faro- penem to and its impact on the morphology of gram - positive and gram - negative bacteria 显示文摘 | Dalhoff A Nasu T Okamoto K | 2003 | Chemotherapy2003，49，4： | 1 |
| 11 | Susceptibility patterns of bacterial isolates from hospitalized patients with respir- atory infections(MOXIAKTIV Study) 显示文摘 | Jacbos E Dalhoff A Korfmann G | 2009 | Int J Antimi- crob Agents2009，33，1： | 1 |
| 12 | Target affinities of faropenem to and its impact on the morphology of gram-positive and gram-negative bacteria显示文摘 | Dalhoff A Nasu T Okamoto K | 2003 | Chemother- apy2003，49，4： | 1 |
| 13 | Pharmacokinetics, safety, and tolerability of ascending single doses of moxifloxacin, a new 8-metnoxy quinolone, administered to healthy subjects 显示文摘 | Stass H Dalhoff A Kubitza D | 1998 | Antimicrob Agents Chemother1998，42，8： | 1 |
| 14 | Beta-lactamase stabili- ty of faropenem显示文摘 | Dalhoff A Nasu T Okamoto K | 2003 | Chemotherapy2003，49，5： | 1 |
| 15 | Beta-lactamase stability of faropenem 显示文摘 | Dalhoff A Nasu T Okamoto K | 2003 | Chemotherapy2003，49，5： | 1 |
| 16 | Towards targeted prescribing: will the cure for antimicrobial resistan~e be specific, directed therapy through improved diagnostic testing? 显示文摘 | Peterson LR Dalhoff A | 2004 | J Antimicrob Chemother2004，53，6： | 1 |
| 17 | Pharmacokinetics, safety, and tolerability of ascending single doses of moxifloxacin, a new 8-methoxy quinolone, administered to healthy subjects显示文摘 | STASS H DALHOFF A KUBITZA D | 1998 | Antimicrob Agents Chemother1998，42，8： | 1 |
| 18 | Target affinities of faropenem to and its impact on the morphology of gram- positive and gram-negative bacteria 显示文摘 | Dalhoff A Nasu T Okamoto K | 2003 | Chemolherapy2003，49，4： | 1 |
| 19 | In vitro activity of BAY 12-8039,a new 8-methoxyqunolone显示文摘 | Dalhoff A Petersen U Endermann R | 1996 | Chemotherapy1996，42，6： | 1 |
| 20 | Targe taffinities of faropenem to and its impact on the morphology of gram-positive and gram-negative bacteria 显示文摘 | DALHOFF A NASU T OKAMOTO K | 2003 | Chemotherapy2003，49，4： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员